Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
19 nov. 2024 16h05 HE
|
Regen BioPharma, Inc.
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into...